These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38542194)

  • 21. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine Oxidase B Expression Correlates with a Poor Prognosis in Colorectal Cancer Patients and Is Significantly Associated with Epithelial-to-Mesenchymal Transition-Related Gene Signatures.
    Yang YC; Chien MH; Lai TC; Su CY; Jan YH; Hsiao M; Chen CL
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
    Clarke CN; Lee MS; Wei W; Manyam G; Jiang ZQ; Lu Y; Morris J; Broom B; Menter D; Vilar-Sanchez E; Raghav K; Eng C; Chang GJ; Simon I; Bernards R; Overman M; Mills GB; Maru D; Kopetz S
    Ann Surg Oncol; 2017 Dec; 24(13):4051-4058. PubMed ID: 28936799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers.
    Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptomic Profiling Reveals an Enhancer RNA Signature for Recurrence Prediction in Colorectal Cancer.
    Sahu D; Lin CC; Goel A
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.
    Shi M; Beauchamp RD; Zhang B
    PLoS One; 2012; 7(7):e41292. PubMed ID: 22844451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples.
    Zhu J; Deane NG; Lewis KB; Padmanabhan C; Washington MK; Ciombor KK; Timmers C; Goldberg RM; Beauchamp RD; Chen X
    Sci Rep; 2016 Sep; 6():33273. PubMed ID: 27623752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
    Chen Q; Tang P; Huang H; Qiu X
    Front Immunol; 2022; 13():934124. PubMed ID: 35958575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
    Sho S; Court CM; Winograd P; Russell MM; Tomlinson JS
    J Surg Oncol; 2017 Dec; 116(8):996-1004. PubMed ID: 28767131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 35. Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing.
    Kishigami F; Tanaka Y; Yamamoto Y; Ueno T; Kojima S; Sato K; Inoue S; Sugaya S; Ishihara S; Mano H; Kawazu M
    Cancer Med; 2022 Sep; 11(18):3457-3470. PubMed ID: 35343095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
    Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
    J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification.
    Novielli P; Romano D; Magarelli M; Bitonto PD; Diacono D; Chiatante A; Lopalco G; Sabella D; Venerito V; Filannino P; Bellotti R; De Angelis M; Iannone F; Tangaro S
    Front Microbiol; 2024; 15():1348974. PubMed ID: 38426064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of cuproptosis-related subtypes and development of a prognostic signature in colorectal cancer.
    Huang Y; Yin D; Wu L
    Sci Rep; 2022 Oct; 12(1):17348. PubMed ID: 36253436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring and validating the prognostic value of pathomics signatures and genomics in patients with cutaneous melanoma based on bioinformatics and deep learning.
    Li X; Yu X; Tian D; Liu Y; Li D
    Med Phys; 2023 Nov; 50(11):7049-7059. PubMed ID: 37722701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.
    Sanz-Pamplona R; Berenguer A; Cordero D; Riccadonna S; Solé X; Crous-Bou M; Guinó E; Sanjuan X; Biondo S; Soriano A; Jurman G; Capella G; Furlanello C; Moreno V
    PLoS One; 2012; 7(11):e48877. PubMed ID: 23145004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.